Neil Warma appointed President and CEO of ProMIS Neurosciences, effective August 1, 2024

ProMIS Neurosciences Inc.

Base salary of $500,000 with annual discretionary bonus target of 50% of base salary.
Granted option to purchase 1,144,122 common shares (Initial Award) and 490,338 shares (Performance Award) at $1.15 per share.
Initial Award vests 25% on grant, remainder ratably over 36 months; Performance Award vests 25% when 10-day VWAP exceeds 3x exercise price, remainder over 36 months.
Severance: 12 months' salary plus pro-rated bonus and time-based option acceleration on non-CIC termination; 18 months' salary plus benefits on change-in-control termination.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Neil Warma

President and Chief Executive Officer

PMN · ProMIS Neurosciences Inc.

Effective: 2024-08-01
Filed: October 10, 2024, 7:59 PM ET

On October 8, 2024, ProMIS Neurosciences Inc. (the “Company”) appointed Neil Warma as the President and Chief Executive Officer (“CEO”) of the Company, effective August 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Neil Warma was appointed as President and Chief Executive Officer at ProMIS Neurosciences Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On October 8, 2024, ProMIS Neurosciences Inc. (the “Company”) appointed Neil Warma as the President and Chief Executive Officer (“CEO”) of the Company, effective August 1, 2024.

View on SEC.gov

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-013244

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.